Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Maxibrol - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Maxibrol

Approved

STANDARD

Maxibrol

Lejal Laboratories Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 2e02d7cdf640b2cf
Company: Lejal Laboratories Inc.
Type: Standard

Approval Details

Approval Id: 2e02d7cdf640b2cf
Drug Approval Philippines Name: Maxibrol
Product Name: Maxibrol
Registration Number: DRP-7689
Brand Name: Maxibrol
Generic Name: Ambroxol Hydrochloride
Dosage Form: Syrup
Dosage Strength: 15mg per 5mL
Manufacturer: Lejal Laboratories Inc.
Trader: Maxiplex International Phils. Corp.
Issuance Date: 31 March 2023
Expiry Date: 07 February 2028
Pharmacologic Category: Mucolytics
Classification: Over-The-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

2e02d7cdf640b2cf

Type

Standard

Back to Philippines FDA Approvals